0 Items
Select Page

Staphylococcus aureus

Staphylococcal food poisoning results from the consumption of foods containing sufficient amounts of one, or more preformed enterotoxins. Food poisoning is characterised by rapid onset and symptoms including nausea, violent vomiting and abdominal cramping, with or without diarrhoea.

The Native Antigen Company offers an extensive panel of monoclonal antibodies to several types of Staphylococcus enterotoxin.

Staphylococcus Background

Staphylococcus aureus is a gram-positive, non-spore-forming bacterium, that is a member of the Staphylococcus genus, which belongs to the family Staphylococcaceae. First recognised in 1880, S. aureus exists in many individuals as part of the normal microbiota, inhabiting the skin, nasal passages and respiratory tract. Pathogenic S. aureus secrete a range of potent toxins, which are a major cause of many pathogenic conditions in humans worldwide.

Enterotoxins, produced by S. aureus, are a major cause of food poisoning and over 30 enterotoxins have been identified to date. Staphylococcus aureus enterotoxin B (SEB) and SEA are recognised as the most potent enterotoxins within the Staphylococcal toxin family. SEB and SEA enterotoxin also act as a potent bacterial superantigen, binding to and stimulating T lymphocytes and major histocompatibility antigens (MHC) on antigen presenting cells of the immune system. Two separate domains of the 28kDa SEB protein are responsible for the two different functions of the toxin (Fries, B).

Staphylococcus aureus enterotoxins G and I have been associated with minor food poisoning outbreaks in Taiwan. Both toxins are heat-stable and are transmitted to humans via contaminated foods including meat, meat products and unpasteurised dairy products. Both enterotoxin I and G have also been linked to cases of toxic shock syndrome, Staphylococcal scarlet fever and neonatal enteropathy.

SEB and SEA are considered to be major causes of food-borne, infection-causing food poisoning. The clinical symptoms of intoxication include fever, myalgia, vomiting, diarrhoea, headaches and in some cases shock. Currently there is no specific treatment for SEB or SEA mediated disease or shock. The condition is often self-limiting, but support with hydration is often required. Currently, no licensed vaccine or antitoxin has been successfully developed (Ortega E).

References

  1. Fries BC, Varshney AK. 2013. Bacterial Toxins-Staphylococcal Enterotoxin B. Microbiol Spectr. Dec;1(2)
  2. Ortega E, Abriouel H, Lucas R, Gálvez A. 2010. Multiple roles of Staphylococcus aureus enterotoxins

Staphylococcus aureus Antibodies

We are pleased to offer a wide range of antibodies, specific to different S. aureus enterotoxins to provide a range of options for studying these bacteria. Our Staphylococcus antibodies include examples specific to enterotoxin A, B, E and I.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Diagnosing HIV in resource-limited settings

In this blog, we discuss the need for improved point-of-care (PoC) diagnostics for HIV and present the virus's cellular mechanism to illustrate our new range of HIV antigens and antibodies. HIV in the developed world On June 5th 1981 in Los Angeles, California, 5...

Our Product Pipeline

If you’ve been following us on social media recently, you might have noticed that we’ve been releasing a lot of new antigens and antibodies. In this blog, we explain how we use the WHO R&D Blueprint to guide our product development and present some highlights from...

From Outbreak to Epidemic: A Short History of The Ebola Virus

In the first of a two-part series, we discuss the history of the Ebola virus up to the ongoing outbreak in the Democratic Republic of Congo, and why this disease has been so challenging to fight. The 2014/15 epidemic In the summer of 2014, the world watched as the...

ELISA Formats for Infectious Disease Diagnostics

The field of diagnostics is rapidly developing, yet ELISA and PCR methods remain the most commonly used techniques in the diagnosis of bacterial and viral infections. In this blog, we discuss the advantages of using serological methods over molecular, PCR-based...

The world’s most extensive range of NS1-specific antibodies for flavivirus research

The Native Antigen Company first gained prominence in 2016, when it developed highly pure Zika virus NS1 protein during the 2015/2016 epidemic. Since then, the company has developed an extensive range of highly specific antigens, antibodies and immunoassays for...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

12 + 6 =

Live Customer Feedback

Join our mailing list

* indicates required